Patients with acid, high-fat and low-protein diet have higher laryngopharyngeal reflux episodes at the impedance-pH monitoring
To assess the impact of diet on the occurrence of proximal reflux episodes at the multichannel intraluminal impedance-pH monitoring (MII-pH) in patients with laryngopharyngeal reflux (LPR).
Patients with LPR symptoms and findings were recruited from three European hospitals. The LPR diagnostic was confirmed through MII-pH and patients were benefited from gastrointestinal (GI) endoscopy. Regarding the types of reflux at the MII-pH (acid, nonacid, mixed), patients received a 3 month-therapy based on the association of alkaline, low-fat and high-protein diet, proton pump inhibitors, alginate or magaldrate. Reflux symptom score (RSS) and reflux sign assessment (RSA) were used to evaluate laryngeal and extra-laryngeal symptoms and findings from pretreatment to posttreatment. The Global Refluxogenic Score (GRES) was used to assess the refluxogenic potential of the diet of the patients at baseline and posttreatment. The relationship between GRES severity; the MII-pH findings; GI endoscopy; and the therapeutic response was explored through multiple linear regression.
Eighty-five LPR patients were included. The mean GRES significantly improved from pretreatment (50.7 ± 23.8) to posttreatment (27.3 ± 23.2; P = 0.001). Similarly, RSS and RSA significantly improved from baseline to posttreatment. The baseline GRES was significantly associated with the occurrence of proximal reflux episodes at the MII-pH (P = 0.001). Trends were found regarding the association between GRES and the occurrence of esophagitis (P = 0.06) and between hiatal hernia and DeMeester score (P = 0.06). There was a significant and strong association between the concomitant respect of diet and medication and the improvement of RSS (P = 0.001).
The consumption of high-fat, low-protein, high-sugar, acid foods, and beverages is associated with a higher number of proximal reflux episodes at the MII-pH, according to the global refluxogenic score of LPR patients.
KeywordsReflux Laryngitis Impedance pH monitoring Laryngopharyngeal Diet Foods Beverages
Vesale Grant and IRIS-Recherche Grant (Foundation Roi Baudouin).
Compliance with ethical standards
Conflict of interest
The authors have no conflicts of interest.
- 3.Lechien JR, Huet K, Khalife M et al (2019) Alkaline, protein, low-fat and low-acid diet in laryngopharyngeal reflux disease: our experience on 65 patients. Clin Otolaryngol Off J ENT-UK Off J Neth Soc Oto-Rhino-Laryngol Cervico-Facial Surg 44(3):379–384. https://doi.org/10.1111/coa.13269 CrossRefGoogle Scholar
- 14.Hoppo T, Komatsu Y, Nieponice A, Schrenker J, Jobe BA (2012) toward an improved understanding of isolated upright reflux: positional effects on the lower esophageal sphincter in patients with symptoms of gastroesophageal reflux. World J Surg 36(7):1623–1631. https://doi.org/10.1007/s00268-012-1537-9 CrossRefPubMedGoogle Scholar
- 15.Lechien JR, Rodriguez A, Dequanter D, Bobin F, Mouawad F, Muls V, Huet K, Harmegnies B, Remacle S, Finck C, Saussez S (2019) Validity and reliability of the reflux sign assessment (RSA). Ann Otol Rhinol LaryngolGoogle Scholar
- 17.Siupsinskiene N, Adamonis K (2003) Diagnostic test with omeprazole in patients with posterior laryngitis. Med Kaunas Lith 39(1):47–55Google Scholar
- 18.Chappity P, Kumar R, Deka RC, Chokkalingam V, Saraya A, Sikka K (2014) Proton pump inhibitors versus solitary lifestyle modification in management of laryngopharyngeal reflux and evaluating who is at risk: scenario in a developing country. Clin Med Insights Ear Nose Throat 7:1–5. https://doi.org/10.4137/CMENT.S13799 CrossRefPubMedPubMedCentralGoogle Scholar
- 19.Nanda MS (2016) Role of adjuvant lifestyle modifications in patients with laryngopharyngeal reflux disease in hilly. Int J Sci Study 3(10):6Google Scholar
- 25.Shapiro M, Green C, Bautista JM et al (2007) Assessment of dietary nutrients that influence perception of intra-oesophageal acid reflux events in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 25(1):93–101. https://doi.org/10.1111/j.1365-2036.2006.03170.x CrossRefPubMedGoogle Scholar
- 38.Richter JE (2000) Gastroesophageal reflux disease in the older patient: presentation, treatment, and complications. Am J Gastroenterol 95(2):368–373. https://doi.org/10.1111/j.1572-0241.2000.t01-1-01791.x CrossRefPubMedGoogle Scholar
- 39.de Bortoli N, Guidi G, Martinucci I et al (2016) Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: a comparative study. Dis Esophagus 29(2):197–204. https://doi.org/10.1111/dote.12319 CrossRefPubMedGoogle Scholar
- 40.López-Colombo A, Pacio-Quiterio MS, Jesús-Mejenes LY et al (2017) Risk factors associated with gastroesophageal reflux disease relapse in primary care patients successfully treated with a proton pump inhibitor. Rev Gastroenterol Mex 82(2):106–114. https://doi.org/10.1016/j.rgmx.2016.09.001 CrossRefPubMedGoogle Scholar
- 51.Pehl C, Waizenhoefer A, Wendl B, Schmidt T, Schepp W, Pfeiffer A (1999) Effect of low and high fat meals on lower esophageal sphincter motility and gastroesophageal reflux in healthy subjects. Am J Gastroenterol 94(5):1192–1196. https://doi.org/10.1111/j.1572-0241.1999.01064.x CrossRefPubMedGoogle Scholar